Complete pelvic lymphadenectomy in patients with clinical early, grade I and II endometrioid corpus cancer

Anticancer Research

Volumn 29, Issue 7, 2009, Pages 2781-2785

  Fotiou, Stelios ^a   Trimble, Edward L ^b   Papakonstantinou, Katerina ^a   Kondi Pafiti, Agatha ^a   Panoskaltsis, Theo ^a   Deliconstantinos, George ^a   Creatsas, George ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Complete pelvic lymphadenectomy; Endometrial cancer; Favorable histological characteristics; Pelvic nodal involvement

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED;

EID: 69249184405     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin 56: 106-130, 2006.
2. Boronow RC, Morrow CP, Creasman WT, Disaia PJ, Silverberg SG, Miller A and Blessing JA: Surgical staging in endometrial cancer: Clinical-pathologic findings of a prospective study. Obstet Gynecol 63: 825-832, 1984. (Pubitemid 14105231)
3. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE and Heller PB: Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study. Cancer 60: 2035-2041, 1987.
4. Hacker NF: Uterine cancer. In: Practical Gynecologic Oncology. 4th ed. Berek JS and Hacker NF (eds.). Philadelphia, Lippincott Williams & Wilkins, pp. 397-442, 2005.
5. Kadar N, Malfetano JH and Homesley HD: Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus. Implications for therapy. Obstet Gynecol 80: 655-659, 1992.
6. Ben-Shachar I, Pavelka J, Cohn DE, Copeland LJ, Ramirez N, Manolitsas T and Fowler JM: Surgical staging for patients presenting with grade 1 endometrial carcinoma. Obstet Gynecol 105: 487-493, 2005. (Pubitemid 40271211)
7. Chi DS, Barakat RR, Palayekar MJ, Levine DA, Sonoda Y, Alektiar K, Brown CL and Abu-Rustum NR: The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer 18: 269-273, 2008.
8. Maggino T, Romagnolo C, Zola P, Sartori E, Landoni F and Gadducci A: An analysis of approaches to the treatment of endometrial cancer in western Europe: a CTF study. Eur J Cancer 31A: 1993-1997, 1995. (Pubitemid 26023089)
9. Kitchener H, Redman CW, Swart AM, Amos CL on behalf of ASTEC Study Group. ASTEC: A study in the treatment of endometrial cancer. A randomized trial of lymphadenectomy in the treatment of endometrial cancer. Gynecol Oncol 101(suppl 1): S21-S22, 2006.
10. Aalders JG and Thomas G: Endometrial cancer-revisiting the importance of pelvic and para aortic lymph nodes. Gynecol Oncol 104: 222-231, 2007.
11. Lutman CV, Havrilesky LJ, Cragun JM, Secord AA, Calingaert B, Berchuck A, Clarke-Pearson DL and Soper JT: Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol Oncol 102: 92-97, 2006. (Pubitemid 43870232)
12. Chan JK, Urban R, Cheung MK, Shin JY, Husain A, Teng NN, Berek JS, Walker JL, Kapp DS and Osann K: Lymphadenectomy in endometrioid uterine cancer staging. How many lymph nodes are enough? A study of 11,443 patients. Cancer 109: 2454-2460, 2007.
13. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD and Graham JE: Relationship between surgical-pathologic risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40: 55-65, 1991.
14. Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G and Podratz KC: Low-risk corpus cancer: Is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 182: 1506-1519, 2008.
15. Case AS, Rocconi RP, Straughn JM Jr, Conner M, Novak L, Wang W and Huh WK: A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer. Obstet Gynecol 108: 1375-1379, 2006. (Pubitemid 44901010)
16. Obermair A, Geramou M, Gücer F, Denison U, Graf AH, Kapshammer E, Medl M, Rosen A, Wierrani F, Neunteufel W, Freeh I, Speiser P, Kainz C and Breitenecker G: Endometrial cancer: accuracy of the finding of a well-differentiated tumor at dilatation and curettage compared to the findings at subsequent hysterectomy. Int J Gynecol Cancer 9: 383-386, 1999.
17. Kinkel K, Kaji Y, Yu KK, Segal MR, Lu Y, Powell CB and Hricak H: Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 212: 711-718, 1999. (Pubitemid 29410973)
18. Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos S, Cho KR, Copeland L, Eifel P, Jaggernauth W, Jhingran A, Kapp DS, Kavanagh J, Lipscomb GH, Lurain JR 3rd, Morgan RJ Jr, Nag S, Partridge EE, Powell CB, Remmenga SW, Reynolds RK, Small W Jr, Soper J and Teng N; National Comprehensive Cancer Network: Uterine cancers. J Natl Compr Cane Netw 4: 438-462, 2006.
19. Maggino T, Romagnolo C, Landoni F, Sartori E, Zola P and Gadducci A: An analysis of approaches to the management of endometrial cancer in North America: a CTF study. Gynecol Oncol 68: 274-279, 1998. (Pubitemid 28183499)
20. Frumovitz M, Singh DK, Meyer L, Smith DH, Wertheim I, Resnik E and Bodurka DC: Predictors of final histology in patients with endometrial cancer. Gynecol Oncol 95: 463-468, 2004. (Pubitemid 39592505)
21. Sanjuan A, Cobo T, Pahisa J, Escaramis G, Ordi J, Ayuso JR, Garcia S, Hernández S, Torné A, Martínez Román S, Lejárcegui JA and Vanrell JA: Preoperative and intraoperative assessment of myometrial invasion and histologic grade in endometrial cancer: role of magnetic resonance imaging and frozen section. Int J Gynecol Cancer 16: 385-390, 2006.
22. Orr JW Jr, Roland PY, Leichter D and Orr PF: Endometrial cancer: is surgical staging necessary? Curr Opin Oncol 13: 408-412, 2001.
23. Fanning J, Hoffman ML, Andrews SJ, Harrah AW and Feldmeier JJ: Cost-effectiveness analysis of the treatment for intermediate risk endometrial cancer: postoperative brachytherapy vs. observation. Gynecol Oncol 93: 632-636, 2004. (Pubitemid 38766047)
24. Barakat RR, Lev G, Hummer AJ, Sonoda Y, Chi DS, Alektiar KM and Abu-Rustum NR: Twelve-year experience in the management of endometrial cancer: A change in surgical and postoperative radiation approaches. Gynecol Oncol 105: 150-156, 2007. (Pubitemid 46441452)